News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
750,337 Results
Type
Article (45469)
Company Profile (291)
Press Release (704560)
Multimedia
Podcasts (96)
Webinars (22)
Section
Business (209113)
Career Advice (2125)
Deals (36155)
Drug Delivery (137)
Drug Development (82942)
Employer Resources (175)
FDA (17126)
Job Trends (15295)
News (354248)
Policy (33747)
Tag
2027 BioCapital Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (2760)
Accelerated approval (45)
Adcomms (28)
Allergies (172)
Alliances (51297)
ALS (210)
Alzheimer's disease (1812)
Antibody-drug conjugate (ADC) (437)
Approvals (17474)
Artificial intelligence (661)
Autoimmune disease (269)
Automation (54)
Bankruptcy (364)
Best Places to Work (11885)
BIOSECURE Act (20)
Biosimilars (221)
Biotechnology (197)
Bladder cancer (186)
Brain cancer (71)
Breast cancer (736)
Cancer (5762)
Cardiovascular disease (462)
Career advice (1798)
Career pathing (43)
CAR-T (328)
CDC (55)
Celiac Disease (3)
Cell therapy (879)
Cervical cancer (47)
Clinical research (71615)
Collaboration (2078)
Company closure (5)
Compensation (1334)
Complete response letters (81)
COVID-19 (2819)
CRISPR (109)
C-suite (1088)
Cystic fibrosis (153)
Data (7618)
Decentralized trials (3)
Denatured (32)
Depression (161)
Dermatology (76)
Diabetes (581)
Diagnostics (7064)
Digital health (55)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (321)
Drug pricing (209)
Drug shortages (32)
Duchenne muscular dystrophy (277)
Earnings (92419)
Editorial (65)
Employer branding (21)
Employer resources (154)
Events (121856)
Executive appointments (1083)
FDA (20786)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (15)
Frontotemporal dementia (34)
Funding (1731)
Gene editing (236)
Generative AI (57)
Gene therapy (712)
GLP-1 (1052)
Government (4874)
Grass and pollen (6)
Guidances (405)
Healthcare (19618)
HIV (80)
Huntington's disease (56)
IgA nephropathy (95)
Immunology and inflammation (296)
Immuno-oncology (90)
Indications (176)
Infectious disease (3157)
Inflammatory bowel disease (208)
Inflation Reduction Act (15)
Influenza (137)
Intellectual property (284)
Interviews (330)
IPO (16828)
IRA (52)
Job creations (3715)
Job search strategy (1496)
JPM (59)
Kidney cancer (19)
Labor market (97)
Layoffs (567)
Leadership (39)
Legal (8143)
Liver cancer (101)
Longevity (33)
Lung cancer (764)
Lymphoma (428)
Machine learning (60)
Management (60)
Manufacturing (1015)
MASH (181)
Medical device (14494)
Medtech (14597)
Mergers & acquisitions (20548)
Metabolic disorders (1476)
mRNA (205)
Multiple sclerosis (188)
NASH (17)
Neurodegenerative disease (410)
Neuropsychiatric disorders (105)
Neuroscience (3322)
Neurotech (1)
NextGen: Class of 2026 (6793)
Non-profit (4666)
Now hiring (76)
Obesity (690)
Opinion (298)
Ovarian cancer (211)
Pain (253)
Pancreatic cancer (292)
Parkinson's disease (363)
Partnered (33)
Patents (584)
Patient recruitment (654)
Peanut (63)
People (60666)
Pharmaceutical (60)
Pharmacy benefit managers (34)
Phase 1 (22390)
Phase 2 (31553)
Phase 3 (23423)
Pipeline (8008)
Policy (320)
Postmarket research (2610)
Preclinical (9609)
Press Release (69)
Prostate cancer (292)
Psychedelics (53)
Radiopharmaceuticals (322)
Rare diseases (1067)
Real estate (6112)
Recruiting (71)
Regulatory (26018)
Reports (55)
Research institute (2545)
Resumes & cover letters (370)
Rett syndrome (36)
RNA editing (20)
RSV (89)
Schizophrenia (178)
Series A (291)
Series B (215)
Service/supplier (12)
Sickle cell disease (109)
Special edition (24)
Spinal muscular atrophy (166)
Sponsored (47)
Startups (3756)
State (2)
Stomach cancer (18)
Supply chain (126)
Tariffs (88)
The Weekly (62)
Vaccines (1119)
Venture capital (107)
Weight loss (446)
Women's health (121)
Worklife (20)
Date
Last 7 days (772)
Last 30 days (2675)
Last 365 days (30537)
2026 (10779)
2025 (30679)
2024 (35794)
2023 (40806)
2022 (51980)
2021 (56628)
2020 (55200)
2019 (47981)
2018 (36145)
2017 (33127)
2016 (32603)
2015 (38724)
2014 (32438)
2013 (27612)
2012 (29802)
2011 (30436)
2010 (28427)
Location
Africa (786)
Alabama (92)
Alaska (7)
Arizona (347)
Arkansas (15)
Asia (41292)
Australia (6766)
California (12930)
Canada (3685)
China (1325)
Colorado (556)
Connecticut (574)
Delaware (392)
Europe (90519)
Florida (1935)
Georgia (424)
Hawaii (3)
Idaho (66)
Illinois (1043)
India (91)
Indiana (589)
Iowa (24)
Japan (520)
Kansas (132)
Kentucky (52)
Louisiana (39)
Maine (75)
Maryland (1564)
Massachusetts (9265)
Michigan (355)
Minnesota (713)
Mississippi (7)
Missouri (155)
Montana (36)
Nebraska (29)
Nevada (141)
New Hampshire (87)
New Jersey (3414)
New Mexico (30)
New York (3417)
North Carolina (1648)
North Dakota (9)
Northern California (6444)
Ohio (388)
Oklahoma (24)
Oregon (44)
Pennsylvania (2600)
Puerto Rico (28)
Rhode Island (50)
South America (1163)
South Carolina (85)
South Dakota (2)
Southern California (5085)
Tennessee (208)
Texas (2048)
United States (45860)
Utah (386)
Vermont (1)
Virginia (313)
Washington D.C. (81)
Washington State (1058)
West Virginia (4)
Wisconsin (125)
Wyoming (2)
750,337 Results for "zymtronix catalytic systems inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Revolution Medicines to Present Preclinical Data on Innovative Mutant-Targeted Catalytic RAS(ON) Inhibitor at the 2026 AACR Annual Meeting
April 22, 2026
·
6 min read
Press Releases
Decoy Therapeutics Builds Momentum with Accelerating Execution, Entering a Highly Catalytic Phase with a Clearly Defined Path to Clinical Development of its Antiviral Pipeline
April 10, 2026
·
7 min read
Press Releases
Inspire Medical Systems, Inc. to Present at the BofA Securities 2026 Healthcare Conference
April 29, 2026
·
1 min read
Press Releases
Delcath Systems, Inc. Announces Inclusion of CHEMOSAT Hepatic Delivery System for Melphalan as a Recommended Liver-Directed Regional Therapy Option in the ESMO–EURACAN Clinical Practice Guidelines for Uveal Melanoma
April 6, 2026
·
4 min read
Press Releases
Inspire Medical Systems, Inc. to Report First Quarter 2026 Financial Results on May 4, 2026
April 6, 2026
·
1 min read
Bio NC
Zymtronix and Ginkgo Bioworks Announce Partnership to Produce Enzymes for the Industrialization of Cell-Free Biomanufacturing
Zymtronix and Ginkgo Bioworks announced a partnership to optimize enzymes used in Zymtronix’s proprietary cell-free platform for the production of important ingredients in food, agriculture, cosmetics and pharmaceuticals.
February 16, 2023
·
6 min read
Business
Zymtronix Welcomes Thomas Videbaek to Its Board of Directors
Zymtronix, Inc., a groundbreaking new biotechnology company, today announced that Dr. Thomas Videbaek, biotech industry veteran and former Executive Vice President (EVP) of Novozymes, is joining its Board of Directors.
February 28, 2023
·
2 min read
Press Releases
Quanta System Inc.: Strengthening the U.S. Presence of Italian Laser Technology
March 1, 2026
·
4 min read
Press Releases
Catalytic Health Announces the Launch of Two New Canadian Medical Journals
May 22, 2025
·
2 min read
Press Releases
Verist Inc. Announces Relationship with Basil Systems to Strengthen Life Sciences Offering
February 26, 2026
·
3 min read
1 of 75,034
Next
